Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to describe the initial activity, tolerability, and safety and to identify a recommended dose and regimen of vedolizumab IV administered for treatment of steroid-refractory acute intestinal GvHD in patients who have undergone allo-HSCT.
Inclusion criteria
- Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD)